Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Linton KM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thieblemont C; Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France. catherine.thieblemont@aphp.fr., Karimi YH; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Ghesquieres H; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Cheah CY; Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia., Clausen MR; Vejle Hospital, Vejle, Denmark., Cunningham D; The Royal Marsden NHS Foundation Trust, Sutton, UK., Jurczak W; MSC National Research Institute of Oncology, Kraków, Poland., Do YR; Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Gasiorowski R; Concord Hospital, University of Sydney, Sydney, Australia., Lewis DJ; University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth, UK., Kim TM; Seoul National University Hospital, Seoul, Republic of Korea., van der Poel M; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Maastricht, Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Poon ML; National University Hospital, Singapore, Singapore., Feldman T; John Theurer Cancer Center at Hackensack Meridian Health, Hackensack Meridian Health School of Medicine, Hackensack, NJ, USA., Linton KM; The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, UK., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia - L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Hutchings M; Rigshospitalet and University of Copenhagen, Copenhagen, Denmark., Dinh MH; AbbVie, North Chicago, IL, USA., Kilavuz N; Genmab, Plainsboro, NJ, USA., Soong D; Genmab, Plainsboro, NJ, USA., Mark T; Genmab, Copenhagen, Denmark., Sacchi M; Genmab, Plainsboro, NJ, USA., Phillips T; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.; City of Hope, Duarte, CA, USA., Lugtenburg PJ; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, Department of Hematology, University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Autor:
Linton KM; The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, UK. Electronic address: kim.m.linton@manchester.ac.uk., Vitolo U; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy., Jurczak W; MSC National Research Institute of Oncology, Kraków, Poland., Lugtenburg PJ; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands., Gyan E; Service d'Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire de Tours, CIC INSERM U1415, Tours, France., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia-L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Christensen JH; Odense University Hospital, Odense, Denmark., Hess B; Medical University of South Carolina, Charleston, SC, USA., Tilly H; Centre Henri Becquerel, Université de Rouen, Rouen, France., Cordoba R; Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Lewis DJ; University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth, UK., Okada C; Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA., Hutchings M; Rigshospitalet and University of Copenhagen, Copenhagen, Denmark., Clausen MR; Vejle Hospital, Vejle, Denmark., Sancho JM; Catalan Institute of Oncology (ICO), ICO Hospital Germans Trias i Pujol, Badalona, Spain., Cochrane T; Gold Coast University Hospital, Southport, QLD, Australia., Leppä S; University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Chamuleau MED; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands., Gernhardt D; Genmab, Plainsboro, NJ, USA., Altıntaş I; Genmab, Utrecht, Netherlands., Liu Y; Genmab, Plainsboro, NJ, USA., Ahmadi T; Genmab, Plainsboro, NJ, USA., Dinh MH; AbbVie, North Chicago, IL, USA., Hoehn D; Genmab, Plainsboro, NJ, USA., Favaro E; Genmab, Copenhagen, Denmark., Elliott B; Genmab, Plainsboro, NJ, USA., Thieblemont C; Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France., Vose JM; University of Nebraska Medical Center, Omaha, NE, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Aug; Vol. 11 (8), pp. e593-e605. Date of Electronic Publication: 2024 Jun 15.
Autor:
Linton KM; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, The Manchester Cancer Research Centre, University of Manchester, Manchester, UK., Specht L; Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Pavlovsky A; Department of Hematology, Fundaleu Clinical Research Center, Buenos Aires, Argentina.; Centro de Helmatología Pavlovsky, Medical Director, Buenos Aires, Argentina., Thompson CA; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Kimby E; Department of Medicine Karolinska Institutet, Center of Hematology, Stockholm, Sweden., de Jong D; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nastoupil LJ; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cottereau AS; Department of Nuclear Medicine, Cochin Hospital, APHP, University of Paris Cité, Paris, France., Casulo C; Department of Medicine, University of Rochester, Rochester, New York, USA., Sarkozy C; Hematology Department, Institut Curie, Saint Cloud, France., Okosun J; Centre for Haemato-Oncology Barts Cancer Institute, Queen Mary University of London, London, UK.
Publikováno v:
Hematological oncology [Hematol Oncol] 2024 Nov; Vol. 42 (6), pp. e3205. Date of Electronic Publication: 2023 Jul 22.
Autor:
Shotton R; The Christie NHS Foundation Trust, Manchester, United Kingdom., Broadbent R; The Christie NHS Foundation Trust, Manchester, United Kingdom., Alchawaf A; The Christie NHS Foundation Trust, Manchester, United Kingdom., Mohamed MB; The Christie NHS Foundation Trust, Manchester, United Kingdom., Gibb A; The Christie NHS Foundation Trust, Manchester, United Kingdom., Martinez-Calle N; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Fox CP; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; School of Medicine, University of Nottingham, Nottingham, United Kingdom., Bishton M; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Pender A; Department of Medicine, The Royal Marsden Hospital, London, United Kingdom., Gleeson M; Haematology, The Royal Marsden Hospital, London, United Kingdom., Cunningham D; Haematology, The Royal Marsden Hospital, London, United Kingdom., Davies A; Cancer Research UK/NIHE Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom., Yadollahi S; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Eyre TA; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Collins G; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Djebbari F; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Kassam S; Haematology, King's College Hospital, London, United Kingdom., Garland P; Haematology, King's College Hospital, Princess Royal Site, Kent, United Kingdom., Watts E; Haematology, Freeman Hospital, Newcastle, United Kingdom., Osborne W; Haematology, Freeman Hospital, Newcastle, United Kingdom., Townsend W; Haematology, University College Hospital London, London, United Kingdom., Pocock R; Haematology, University College Hospital London, London, United Kingdom., Ahearne MJ; Haematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom., Miall F; Haematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom., Wang X; Statistics Group, Clinical Outcome Unit, Digital Services, The Christie NHS Foundation Trust, Manchester, United Kingdom., Linton KM; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.
Publikováno v:
Blood advances [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 878-888.
Autor:
Di Ciaccio PR; Department of Haematology, The Canberra Hospital, Garran, ACT, Australia.; College of Health and Medicine, Australian National University, Canberra, ACT, Australia., Polizzotto MN; Department of Haematology, The Canberra Hospital, Garran, ACT, Australia.; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Cwynarski K; Department of Haematology, University College Hospital, London, United Kingdom., Gerrie AS; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, BC, Canada., Burton C; Department of Haematology, St James University Hospital, Leeds, United Kingdom., Bower M; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Kuruvilla J; Division of Oncology and Haematology, Princess Margaret Cancer Centre, The Princess Margaret Hospital, Toronto, ON, Canada., Montoto S; Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., McKay P; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Fox CP; University Hospitals NHS Trust, Nottingham, United Kingdom.; School of Medicine, University of Nottingham, Nottingham, United Kingdom., Milliken S; Department of Haematology, St Vincent's Hospital, Sydney, NSW, Australia., Jiamsakul A; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Osborne W; Department of Haematology, Freeman Hospital, Newcastle upon Tyne NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom., Collins GP; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Manos K; Department of Haematology, Flinders Medical Centre, Adelaide, SA, Australia., Linton KM; The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom.; Manchester Cancer Research Centre, University of Manchester, Manchester, United Kingdom.; Manchester Academic Health Science Centre, Manchester, United Kingdom., Iyengar S; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Kassam S; King's College Hospital, London, United Kingdom., Limei MP; Department of Haematology, National University Hospital, Singapore., Kliman D; Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia., Wong Doo N; Department of Haematology, Concord Repatriation General Hospital, Sydney, NSW, Australia.; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia., Watson AM; Department of Haematology, Liverpool Hospital, Sydney, NSW, Australia., Fedele P; School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.; Haematology Department, Monash Health, Clayton, VIC, Australia., Yannakou CK; Department of Molecular Oncology and Cancer Immunology, Epworth Freemasons Hospital, Epworth HealthCare, Melbourne, Victoria, Australia., Hunt S; Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Ku M; Department of Haematology, St Vincent's Hospital, Melbourne, VIC, Australia., Sehn LH; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, BC, Canada., Smith A; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom., Renshaw H; Department of Haematology, University College Hospital, London, United Kingdom., Maxwell A; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Liu Q; Division of Oncology and Haematology, Princess Margaret Cancer Centre, The Princess Margaret Hospital, Toronto, ON, Canada., Dhairyawan R; Department of Infection and Immunity, Barts Health NHS Trust, London, United Kingdom., Ferguson G; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Pickard K; Department of Haematology, Freeman Hospital, Newcastle upon Tyne NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom., Painter D; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom., Thakrar N; Department of Haematology, University College Hospital, London, United Kingdom., Song KW; Leukemia/Bone Marrow Transplant Program of British Columbia and Division of Hematology, BC Cancer, University of British Columbia, Vancouver, BC, Canada., Hamad N; Department of Haematology, St Vincent's Hospital, Sydney, NSW, Australia.; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.; School of Medicine, University of Notre Dame, Perth, WA, Australia.
Publikováno v:
Blood [Blood] 2024 Jan 11; Vol. 143 (2), pp. 152-165.
Autor:
Eyre TA; Department of Haematology, Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Bishton MJ; Department of Haematology, Nottingham University Hospitals NHS Foundation Trust, Oxford, UK.; Translational Medical Sciences, University of Nottingham, Nottingham, UK., McCulloch R; Department of Haematology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK., O'Reilly M; Department of Haematology, University College London Hospitals, London, UK., Sanderson R; Department of Haematology, King's College Hospital, London, UK., Menon G; Department of Cellular Pathology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Iyengar S; Department of Haematology, The Royal Marsden Hospital, London, UK., Lewis D; Department of Haematology, Derriford Hospital, Plymouth, UK., Lambert J; Department of Haematology, University College London Hospitals, London, UK., Linton KM; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK., McKay P; Beatson West of Scotland Cancer Centre, Glasgow, UK.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jan; Vol. 204 (1), pp. 108-126. Date of Electronic Publication: 2023 Oct 25.
Autor:
Opat S; Monash Health and Monash University, Clayton, VIC, Australia., Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Hu B; Levine Cancer Institute/Atrium Health, Charlotte, NC., Linton KM; Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester, United Kingdom., McKay P; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Leitch S; North Shore Hospital, Auckland, New Zealand., Coleman M; Clinical Research Alliance, Lake Success, NY., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli,' and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy., Jin J; The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China., Sun M; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Sobieraj-Teague M; Flinders Medical Centre, Bedford Park, SA, Australia., Browett P; Auckland City Hospital, Grafton, New Zealand., Ke X; Peking University Third Hospital, Beijing, China., Thieblemont C; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncology, Paris University Diderot, Paris, France., Ardeshna K; University College London Hospitals/University College London Biomedical Research Centre, London, UK., Bijou F; Institut Bergonié, Bordeaux, France., Walker P; Peninsula Private Hospital, Ramsay Health Care, Frankston, VIC, Australia., Hawkes EA; Olivia Newton-John Cancer Research Centre, Austin Health, Heidelberg, VIC, Australia., Ho SJ; St George Hospital, Kogarah, NSW, Australia., Zhou K; Henan Cancer Hospital, Zhengzhou, China., Liang Z; BeiGene, Shanghai, China., Xu J; BeiGene, Ridgefield Park, NJ., Tankersley C; BeiGene, San Mateo, CA., Delarue R; BeiGene, Basel, Switzerland., Co M; BeiGene, San Mateo, CA., Trotman J; Concord Repatriation General Hospital and University of Sydney, Concord, NSW, Australia.
Publikováno v:
Blood advances [Blood Adv] 2023 Nov 28; Vol. 7 (22), pp. 6801-6811.
Autor:
Khwaja J; University College London Hospitals, London, UK., Kirkwood AA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, University College London, UK., Isbell LK; University Medical Center Freiburg, Freiburg., Steffanoni S; IRCCS San Raffaele Scientific Institute, Milan, Italy., Goradia H; Nottingham University Hospitals NHS Trust, Nottingham, UK., Pospiech L; Klinikum Stuttgart, Stuttgart, Germany., Fail T; Freeman Hospital, Newcastle, UK., Nicholson E; Royal Marsden Hospital, London, UK., Fletcher K; King's College Hospital, London, UK., Linton KM; The Christie Hospital, Manchester., Parsons KE; Beatson West of Scotland Cancer Centre, Glasgow., Elmusharaf N; University Hospital of Wales, Cardiff, UK., Eccersley L; St Bartholomew's Hospital, London, UK., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Oxford., Chaganti S; Queen Elizabeth Hospital, Birmingham, UK., Smith J; Aintree University Hospitals NHS Foundation Trust, Liverpool, UK., Thakrar N; University College London Hospitals, London, UK., Kutilina A; University Medical Center Freiburg, Freiburg, Germany., Calimeri T; IRCCS San Raffaele Scientific Institute, Milan, Italy., Martinez-Calle N; Nottingham University Hospitals NHS Trust, Nottingham, UK., El-Sharkawi D; Royal Marsden Hospital, London, UK., Osborne W; Freeman Hospital, Newcastle, UK., Illerhaus G; Klinikum Stuttgart, Stuttgart, Germany., Fox CP; Nottingham University Hospitals NHS Trust, Nottingham., Ferreri AJM; IRCCS San Raffaele Scientific Institute, Milan., Schorb E; University Medical Center Freiburg, Freiburg, Germany., Cwynarski K; University College London Hospitals, London, UK. kate.cwynarski@nhs.net.
Publikováno v:
Haematologica [Haematologica] 2023 Mar 01; Vol. 108 (3), pp. 882-888. Date of Electronic Publication: 2023 Mar 01.